ruxolitinib

Skin Enzymes – Friday Pop Quiz 8/19/2022
The medication that the FDA recently approved for the treatment of this condition inhibits the same enzymes as which of the following? A. Ruxolitinib B. Abrocitinib C. Apremilast D. Adalimumab E. Tofacitinib To find out the correct answer and read the explanation, click here.    Brought to you by our brand partner Derm In-Review.  A product of SanovaWorks. …
Dermatology Industry Joins Fight Against COVID-19
Dermatology industry joins fight against covid-19EPI Health has graciously supported the COVID-19 News and Resource Center. Companies in the dermatology industry are playing a role in the fight against COVID-19. From researching possible treatments and vaccines to modifying production lines for essential products, the following is a listing of dermatology companies and their COVID-19 efforts: AbbVie is researching whether its drug KALETRA� …
Dermatology industry joins fight against covid-19